GOAL-Directed ANalgesia (GOALDAN)

Clinical trial NCT03618082 · UNKNOWN

Trial details

NCT number: NCT03618082
Sponsor: University Hospital, Clermont-Ferrand
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Immediate Severe Postoperative Pain Perioperative Hemodynamic

Start date: 2019-06-06
Primary completion: 2022-05-13
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.